Postoperative Pain Control With Lipossomic Extended Release Bupivacaine
NCT03560362
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Pain, Postoperative
Lung Cancer
Interventions
DRUG:
Bupivacaine liposome
DRUG:
Bupivacaine / Epinephrine
Sponsor
University of Tennessee